ANSTO Health

ANSTO Health is the nuclear medicine division of the Australian Nuclear Science and Technology Organisation, serving as Australia's primary supplier of radiopharmaceuticals and radioisotopes. The organization specializes in the production and distribution of essential diagnostic and therapeutic agents, most notably Technetium-99m, which is utilized in the majority of nuclear medicine procedures globally. Operating from the Lucas Heights facility in New South Wales, ANSTO Health leverages the OPAL multi-purpose reactor to manufacture a diverse portfolio of products including Iodine-131, Gallium-67, and Thallium-201. Their business model encompasses large-scale manufacturing, research and development support, and contract manufacturing services for the global healthcare market. ANSTO Health plays a critical role in the supply chain for oncology, cardiology, and neurology diagnostics across Australia and the Asia-Pacific region.